Enfermedades retinianas y nuevas terapias

Foto de Enfermedades retinianas y nuevas terapias

Foto de University of California Los Angeles

University of California Los Angeles

Los Ángeles, Estados Unidos

Publicaciones en colaboración con investigadores/as de University of California Los Angeles (4)

2020

Correction to: A nonsynonymous mutation in PLCG2 reduces the risk of Alzheimer’s disease, dementia with Lewy bodies and frontotemporal dementia, and increases the likelihood of longevity (Acta Neuropathologica, (2019), 138, 2, (237-250), 10.1007/s00401-019-02026-8)
Acta Neuropathologica

2019

Identification of evolutionarily conserved gene networks mediating neurodegenerative dementia
Nature Medicine, Vol. 25, Núm. 1, pp. 152-164

2018

Efficacy and safety of lampalizumab for geographic atrophy due to age-related macular degeneration: Chroma and spectri phase 3 randomized clinical trials
JAMA Ophthalmology, Vol. 136, Núm. 6, pp. 666-677

2011

Identification of common variants influencing risk of the tauopathy progressive supranuclear palsy
Nature Genetics